Novartis

Basf (8)
Dow chemical (5)
Henkel (1)
Hutchinson (17)
Monsanto (288)
Novartis (10)
Solvay (3)
Union carbide (7)

Synopsis: Chemistry & chemical compounds: Chemistry & chemicals: Chemical companies: Novartis:

Chris Corrigan lectures for Glaxosmithkline and Allergy Therapeutics and consults for Novartis Stallergenes and Allergy Therapeutics.

European Medicines Agency recommends approval of two H1n1 vaccines, from Novartis and Glaxosmithkline. 15 september 2009:

FDA approves four H1n1 vaccines, from CSL Limited, Medimmune LLC, Novartis, and Sanofi Pasteur. 10 september 2009:

Novartis says a trial on 100 subjects shows its H1n1 vaccine is potentially protective for 80%of subjects after one dose and over 90%after two doses. 21 august 2009:

marketed for adults as Coartem by Novartis. By 2013, the end of the current strategy,

Patent blocked India s Supreme court ruled on 1 Â April against an attempt by Swiss drug company Novartis to patent the anticancer drug Gleevec (imatinib mesylate.

The patent claim by Basel-based Novartis on a modified version of Gleevec"fails in both the tests of invention and patentability,

Novartis woes The Japanese health ministry filed a criminal complaint on 9 Â January against Swiss pharmaceutical firm Novartis,

Novartis s Japan unit has acknowledged the complaint on its website. Cloud computing IBM has invested US$1 Â billion in the IBM Watson Group,

< Back - Next >

Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011